Ricerca
« Pagina precedente |
1 - 20 di 81
|
Pagina successiva »
Risultati della ricerca
Seleziona un immagine per l'avvio del slideshow
Understanding reaction mechanisms and structure/reactivity relationships in the electrophilic fluorination of enol esters
1 di 20
Synthetic approaches to heterocyclic systems of pharmaceutical relevance
2 di 20
Catalytic methods for etherification reactions
3 di 20
Investigating streptomyces clavuligerus linear replicons for improved clavulanic acid production
4 di 20
The design and synthesis of small molecule bromodomain inhibitors
5 di 20
Homogeneous hydrogenation and photochemistry as tools in pharmaceutical process development
6 di 20
The design and synthesis of αvβ6 antagonists and PI3K inhibitors as small molecule therapies for respiratory diseases
7 di 20
Novel PI3Kδ inhibitors for the treatment of inflammatory diseases
8 di 20
Chemoselective C-H functionalisation of aliphatic azacycles : utilisation of electrophilic iodine as a mild oxidant
9 di 20
Novel heterocyclic ligands for the lipid kinase PI4KIIIβ : a chemical biology approach
10 di 20
Electrochemically enabled synthesis of substituted isoxazolines
11 di 20
Development of lysine-targeted irreversible inhibitors of PI3Kδ
12 di 20
The design, synthesis and optimisation of αvβ6 antagonists as potential idiopathic pulmonary fibrosis agents
13 di 20
αV integrin antagonists for the treatment of idiopathic pulmonary fibrosis
14 di 20
The design, synthesis and optimisation of CCR4 antagonists for the treatment of asthma
15 di 20
The use of structure-based drug design to optimise protein-ligand interactions
16 di 20
Pharmacological characterisation of small molecule RGD-mimetics targeting αvβ6-mediated activation of TGFβ in idiopathic pulmonary fibrosis
17 di 20
Early application of mechanistic PKPD modelling to guide the preclinical development of a therapeutic mAb targeting complement receptor 2 (CR2/CD21) as a novel target for the treatment of autoimmune disease
18 di 20
The interplay of multiple ADME mechanisms : prediction of hepatic drug-drug interactions from in vitro
19 di 20
New treatments for inflammatory diseases : optimisation and understanding of key processes
20 di 20